Transformation suppressor activity of a Jun transcription factor lacking its activation domain

A Lloyd1, N Yancheva, B Wasylyk

  • 1LGME-CNRS, U184-INSERM, Institut de Chimie Biologique, Faculté de Medecine, Strasbourg, France.

Nature
|August 15, 1991
PubMed

Insights

The oncoprotein c-Jun is essential for Ras-mediated cell transformation. A dominant-negative Jun mutant inhibits Ras transformation and restores normal cell growth, acting as an anti-oncogene.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cellular Transformation

Background:

  • The oncoprotein c-Jun is implicated in Ras-mediated cell transformation.
  • Both c-Jun synthesis and transcription factor activity are upregulated by Ras.
  • c-Jun and Ras cooperate in transformation assays, suggesting distinct but interacting pathways.

Purpose of the Study:

  • To investigate the necessity of c-Jun, potentially with interacting factors, for Ras-mediated cell transformation.
  • To characterize a dominant-negative Jun mutant's effect on transcription and cell transformation.
  • To explore the potential of Jun mutants as anti-oncogenes.

Main Methods:

  • Utilized a dominant-negative mutated transcription factor (Jun mutant) lacking an activation domain.
  • Assessed the inhibition of transcription stimulation by various oncoproteins and a tumor promoter (TPA).
  • Examined the specificity of inhibition for Jun-binding motifs, contrasting with NF-kappa B/Rel motif activation.
  • Evaluated the Jun mutant's anti-oncogenic activity in Ras-transformed cells, assessing growth characteristics and tumorigenicity.

Main Results:

  • The dominant-negative Jun mutant specifically blocks transcription stimulation mediated by Ras and other oncoproteins.
  • Inhibition is specific to Jun-binding motifs, leaving NF-kappa B/Rel activation unaffected.
  • The Jun mutant functions as an anti-oncogene in Ras-transformed cells, inducing reversion to non-transformed phenotypes.
  • Revertant cells exhibit restored anchorage and density-dependent growth and reduced in vivo tumorigenicity.

Conclusions:

  • c-Jun, potentially with interacting partners, is necessary for Ras-mediated cell transformation.
  • Dominant-negative Jun mutants can serve as anti-oncogenes, reversing oncogenic phenotypes.
  • This approach offers a method to study the role of transcription factors in signal transduction and transformation.

Related Concept Videos

RNA Polymerase II Accessory Proteins02:36

RNA Polymerase II Accessory Proteins

Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Eukaryotic Transcription Activators02:42

Eukaryotic Transcription Activators

Transcription activators are proteins that promote the transcription of genes from DNA to RNA. In most cases, these proteins contain two separate domains ‒ a domain that binds to DNA and a domain for activating transcription; however, in some cases, a single domain is responsible for both binding and activation of transcription, as seen in the glucocorticoid receptor and MyoD.
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These domains are...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...